Saurabh Mehta
Cornell University, NY·Public Health & Epidemiology
Simple diagnostic tests that work at the point of care, at a clinic or in the community without a full laboratory, could transform health care where resources are scarce. Before such devices can be trusted, they must be tested on real patients from the populations they are meant to serve.
- Fields
Public Health & Epidemiology
Medicine & Clinical Research
Biomedical Engineering
- Topics
point-of-care diagnostics
PoC
global health
- Grants
- 1 known grant, through Jul 2028
What they work on
- Enable testing of point-of-care diagnostic devices on human samples and patients by providing access to biobanks and diverse patient groups at partner sites in New York, Uganda, Ecuador and India.
- Support project teams in designing validation studies for point-of-care technologies, including statistical design and analysis.
- Work with the center's technology and dissemination cores to identify point-of-care projects ready for human validation and to produce a yearly needs assessment.
- Host device developers for clinical rotations at partner sites and build local capacity so each site can become a recognized center for validating diagnostics.
More about the research
Few developers have access to such patients. This core, part of the PORTENT center on point-of-care (PoC) technologies for nutrition, infection and cancer in global health, exists to close that gap.
Why it matters
Patients in low- and middle-income countries are among the most vulnerable in the world, and that is where point-of-care tests could have the greatest impact. By giving developers easier access to diverse patients and sample collections in Uganda, Ecuador, India and New York, this work could speed the validation of affordable diagnostics for nutrition, infection and cancer. It could also improve local health outcomes in these regions.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Sally McFall
Northwestern University, IL·Biomedical Engineering
Develop a DASH platform test that detects hepatitis C viral RNA from a fingerstick blood sample in 15 minutes, so active infection can be diagnosed in a single step without a laboratory.
Samuel K Sia
Columbia University, NY·Biomedical Engineering
Integrate plasma filtration from whole blood and PRECISE magnetic bead nucleic-acid extraction with plasmonic PCR to create a sample-to-answer hepatitis C RNA test.
J. Tracy
University of Vermont, VT·Public Health & Epidemiology
Explain how INSPIRE's stakeholder-engaged activities led to rapid scale-up of HPV testing in the Peruvian Amazon, using a realist evaluation of the people involved.
The school
Cornell University: 37 labs on PI Pages, $1.6B a year on research, 537 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.